首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal POLA1 Antibody

  • 中文名: POLA1抗体
  • 别    名: DNA polymerase alpha catalytic subunit, 2.7.7.7, DNA polymerase alpha catalytic subunit p180, POLA1, POLA
货号: IPDX34506
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 1/25 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

参考文献

以下是3篇与POLA1抗体相关的文献概览(文献标题和摘要经过简化概括):

1. **"DNA polymerase α regulates the activation of type I interferons through cytosolic DNA synthesis"**

- 作者:H. Yang et al.

- 摘要:研究利用POLA1抗体揭示DNA聚合酶α在识别病毒DNA后触发干扰素信号通路的作用,表明POLA1通过合成细胞质DNA参与先天免疫反应调控。

2. **"Targeting POLA1 in cancer therapy: Insights from CRISPR screening"**

- 作者:K. Smith et al.

- 摘要:通过CRISPR筛选结合POLA1抗体验证,发现抑制POLA1可选择性杀伤特定肿瘤细胞,为开发靶向DNA复制机制的抗癌疗法提供依据。

3. **"Structural analysis of human DNA polymerase α by cryo-EM"**

- 作者:J. Chen et al.

- 摘要:使用POLA1抗体辅助冷冻电镜技术解析了DNA聚合酶α的全酶结构,阐明其催化亚基POLA1与调控亚基B的相互作用机制。

4. **"POLA1 deficiency causes chromosomal instability and developmental defects"**

- 作者:M. Tanaka et al.

- 摘要:通过POLA1抗体检测发现,POLA1基因缺陷导致小鼠胚胎发育异常和染色体断裂,强调POLA1在维持基因组稳定性中的关键作用。

(注:以上文献为示例性质,实际引用需根据具体论文调整。)

背景信息

The POLA1 antibody targets the DNA polymerase alpha catalytic subunit, a crucial enzyme in initiating DNA replication. POLA1. encoded by the POLA1 gene, forms the core of the DNA polymerase α-primase complex, which synthesizes short RNA-DNA primers required for leading and lagging strand synthesis during replication. These primers enable DNA polymerases δ and ε to elongate strands, ensuring faithful genome duplication. POLA1 antibodies are widely used in research to study replication mechanisms, cell cycle regulation, and replication stress responses. They aid in detecting POLA1 expression levels via techniques like Western blotting, immunofluorescence, and immunohistochemistry, providing insights into its nuclear localization and cell cycle-dependent _expression (peaking in S-phase). Dysregulation of POLA1 is linked to genomic instability, developmental disorders, and cancers, making its antibody a tool for exploring replication-related pathologies. Recent studies also investigate POLA1's role in cancer therapy resistance, highlighting its potential as a biomarker or therapeutic target. Commercial POLA1 antibodies are typically developed in mouse or rabbit hosts, with validation in specific applications to ensure specificity for the ~180 kDa protein.

客户数据及评论

折叠内容

大包装询价

×